MétaCan
Menu
Back to cohort
Record W4402031327 · doi:10.1016/j.jtct.2024.08.015

CAST Regimen for GvHD Prophylaxis: A CIBMTR Propensity Score-Matched Analysis

2024· article· en· W4402031327 on OpenAlexfundno aff
A. Samer Al‐Homsi, Todd E. DeFor, Kelli Cole, Frank Cirrone, Andres Suarez-Londono, George Yaghmour, Stéphanie Boisclair, Caitrin Bupp, Stephen R. Spellman

Bibliographic record

VenueTransplantation and Cellular Therapy · 2024
Typearticle
Languageen
FieldHealth Professions
TopicAdolescent and Pediatric Healthcare
Canadian institutionsnot available
FundersNational Institute of Environmental Health SciencesNational Institute of Allergy and Infectious DiseasesOffice of Naval ResearchLegend BiotechNYU Grossman School of MedicinePharmacyclicsTakeda OncologyHealth Resources and Services AdministrationNational Institutes of HealthMorphoSysSeagenBeiGeneAstellas PharmaAdaptive BiotechnologiesKiadis Pharmabluebird bioMedacJazz PharmaceuticalsAmgenRush UniversityHistoGeneticsU.S. Public Health ServiceU.S. Department of DefenseSanofiGlaxoSmithKlineNational Institute on AgingCSL BehringBristol-Myers SquibbAstraZenecaSwedish Orphan BiovitrumOmeros CorporationVertex PharmaceuticalsAlexion PharmaceuticalsMallinckrodt PharmaceuticalsAstellas Pharma USU.S. NavyGateway for Cancer ResearchActinium PharmaceuticalsCareDxNational Heart, Lung, and Blood InstituteNovartis Pharmaceuticals CorporationIncytePfizerAtara BiotherapeuticsNational Cancer InstituteGilead Sciences
KeywordsPropensity score matchingRegimenMedicineInternal medicineOncology

Abstract

fetched live from OpenAlex

Previously, we reported excellent results with the combination of post-transplant cyclophosphamide (PTCy), abatacept, and a short course of tacrolimus (CAST) for the prevention of graft-versus-host disease (GvHD) following peripheral blood haploidentical transplantation. To further substantiate these results, we performed a propensity score-matched analysis. Patients enrolled in the CAST trial were matched with patients from a contemporaneous cohort from the Center for International Blood and Marrow Transplant Research database who received PTCy, tacrolimus, and mycophenolate mofetil, using nearest neighbor propensity score matching. An excellent balance between pairs was achieved as measured by the density distribution and standardized differences of covariates (median 0.09). The rates of acute GvHD grades II to IV at day +120 and 1-year GvHD- and relapse-free survival were 16.7% and 66.7% in the CAST cohort versus 28.6% and 47.6% in the control group, respectively. This trend did not reach statistical significance (P = .14 and .07), possibly due to the small numbers of patients and events. On the other hand, CAST was associated with a statistically significant reduction in the incidence of relapse (9.5% versus 26.2%, P = .045) with improved disease-free survival (85.7% versus 61.9%, P = .01). Our data provides a strong impetus to examine CAST in a randomized clinical trial.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.006
Threshold uncertainty score0.021

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.004
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.003
Bibliometrics0.0010.001
Science and technology studies0.0010.000
Scholarly communication0.0020.001
Open science0.0010.001
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0060.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.116
GPT teacher head0.383
Teacher spread0.266 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2024
Admission routes1
Has abstractno

Explore more

Same venueTransplantation and Cellular TherapySame topicAdolescent and Pediatric HealthcareFrench-language works237,207